Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802917 · ClinicalTrials.gov registry record · NA
To Evaluate Eye Installation-Tear Free
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT02802917: Completed NA study, sponsored by Bayer.
NCT02802917 is a NA study that has completed, run by Bayer. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802917, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The primary objective of this study was to compare the human eye stinging potential of experimental formulas of sun care products \[Sun Protection Factor (SPF) 50 Y49 091, SPF 50 X15 158, SPF 50 X15 160 and SPF 50 X57 162 compared to an industry standard shampoo mixture.
Primary Outcome
Score 0: No discomfort felt Score 1: Faint, barely perceptible discomfort Score 2: Mild, low intensity discomfort that does not prevent the subject from opening lids Score 3: Moderately intense discomfort that interferes with but does not prevent lid opening Score 4: Severe, very intense discomfort that makes voluntary lid opening difficult, requires force to pull lids apart, and results in the subject requesting washout of test article
Interventions
- DRUG SPF 50 Y49 091 (BAY 987516)
- DRUG SPF 50 X15 158 (BAY 987516)
- DRUG SPF 50 X15 160 (BAY 987516)
- DRUG SPF 50 X57 162 (BAY 987516)
- OTHER J & J baby shampoo, X46 046 (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2015-05-15 |
| Est. Completion | 2015-05-24 |
| Phase | NA |
What the finished NCT02802917 record still lists
NCT02802917 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 5 interventions - of which SPF 50 Y49 091 (BAY 987516) is the first listed.
NCT02802917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02802917 about?
NCT02802917 is a clinical study titled "To Evaluate Eye Installation-Tear Free". The primary objective of this study was to compare the human eye stinging potential of experimental formulas of sun care products \[Sun Protection Factor (SPF) 50 Y49 091, SPF 50 X15 158, SPF 50 X15 160 and SPF 50 X57 162 compared to an industry standard shampoo mixture.
What is the current status of trial NCT02802917?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2015-05-15. Estimated completion is 2015-05-24.
What interventions are being tested in trial NCT02802917?
The interventions under investigation include: SPF 50 Y49 091 (BAY 987516) (DRUG), SPF 50 X15 158 (BAY 987516) (DRUG), SPF 50 X15 160 (BAY 987516) (DRUG), SPF 50 X57 162 (BAY 987516) (DRUG), J & J baby shampoo, X46 046 (control) (OTHER).
Who is sponsoring clinical trial NCT02802917?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02802917's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI